AB Science has received approval from the U.S. Food and Drug

AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis

AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , Paris , France General , French , Neuroimmunol Neuroinflamm , Patrick Vermersch , French Agency , University Of Lille , Drug Administration , Amyotrophic Lateral Sclerosis , Expanded Disability Status Scale , Progressive Forms , Multiple Sclerosis , Neurol Neuroimmunol Neuroinflamm , Euronext Paris , Regulations For ,